[1] |
BRAAK H, BRETTSCHNEIDER J, LUDOLPH A C,et al. Amyotrophic lateral sclerosis——a model of corticofugal axonal spread[J]. Nat Rev Neurol, 2013, 9(12):708-714. DOI: 10.1038/nrneurol.2013.221.
|
[2] |
STRONG M J, ABRAHAMS S, GOLDSTEIN L H,et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD):revised diagnostic criteria[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2017, 18(3/4):153-174. DOI: 10.1080/21678421.2016.1267768.
|
[3] |
RUSINA R, VANDENBERGHE R, BRUFFAERTS R. Cognitive and behavioral manifestations in ALS:beyond motor system involvement[J]. Diagnostics (Basel), 2021, 11(4):624. DOI: 10.3390/diagnostics11040624.
|
[4] |
QUINN C, ELMAN L, MCCLUSKEY L,et al. Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS[J]. Neurology, 2012, 79(6):583-588. DOI: 10.1212/WNL.0b013e3182635720.
|
[5] |
崔博,李存江,卫华,等. 肌萎缩侧索硬化认知功能的神经心理学研究[J]. 脑与神经疾病杂志,2020,28(12):743-746.
|
[6] |
YORK C, OLM C, BOLLER A,et al. Action verb comprehension in amyotrophic lateral sclerosis and Parkinson's disease[J]. J Neurol, 2014, 261(6):1073-1079. DOI: 10.1007/s00415-014-7314-y.
|
[7] |
ASH S, OLM C, MCMILLAN C T,et al. Deficits in sentence expression in amyotrophic lateral sclerosis[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2015, 16(1/2):31-39. DOI: 10.3109/21678421.2014.974617.
|
[8] |
BAMBINI V, ARCARA G, MARTINELLI I,et al. Communication and pragmatic breakdowns in amyotrophic lateral sclerosis patients[J]. Brain Lang, 2016, 153/154:1-12. DOI: 10.1016/j.bandl.2015.12.002.
|
[9] |
WOOLLEY S C, RUSH B K. Considerations for clinical neuropsychological evaluation in amyotrophic lateral sclerosis[J]. Arch Clin Neuropsychol, 2017, 32(7):906-916. DOI: 10.1093/arclin/acx089.
|
[10] |
TROJSI F, DI NARDO F, CAIAZZO G,et al. Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS):more than Papez circuit impairment[J]. Brain Imaging Behav, 2021, 15(4):2126-2138. DOI: 10.1007/s11682-020-00408-1.
|
[11] |
TROJSI F, DI NARDO F, SANTANGELO G,et al. Resting state fMRI correlates of Theory of Mind impairment in amyotrophic lateral sclerosis[J]. Cortex, 2017, 97:1-16. DOI: 10.1016/j.cortex.2017.09.016.
|
[12] |
ARSHAD F, PAPLIKAR A, MEKALA S,et al. Social cognition deficits are pervasive across both classical and overlap frontotemporal dementia syndromes[J]. Dement Geriatr Cogn Dis Extra, 2020, 10(3):115-126. DOI: 10.1159/000511329.
|
[13] |
XU Z W, LEE A, NOUWENS A,et al. Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2018, 19(5/6):362-376. DOI: 10.1080/21678421.2018.1433689.
|
[14] |
ILLÁN-GALA I, ALCOLEA D, MONTAL V,et al. CSF sAPPβ,YKL-40,and NfL along the ALS-FTD spectrum[J]. Neurology, 2018, 91(17):e1619-1628. DOI: 10.1212/WNL.0000000000006383.
|
[15] |
AGOSTA F, FERRARO P M, RIVA N,et al. Structural brain correlates of cognitive and behavioral impairment in MND[J]. Hum Brain Mapp, 2016, 37(4):1614-1626. DOI: 10.1002/hbm.23124.
|
[16] |
CONSONNI M, CONTARINO V E, CATRICALÀE,et al. Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis[J]. Neuroimage Clin, 2018, 19:675-682. DOI: 10.1016/j.nicl.2018.05.020.
|
[17] |
GELLERSEN H M, GUO C C, O'CALLAGHAN C,et al. Cerebellar atrophy in neurodegeneration-a meta-analysis[J]. J Neurol Neurosurg Psychiatry, 2017, 88(9):780-788. DOI: 10.1136/jnnp-2017-315607.
|
[18] |
KELLER J, BÖHM S, AHO-ÖZHAN H E A,et al. Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis[J]. Brain Imaging Behav, 2018, 12(3):771-784. DOI: 10.1007/s11682-017-9738-3.
|
[19] |
WITIUK K, FERNANDEZ-RUIZ J, MCKEE R,et al. Cognitive deterioration and functional compensation in ALS measured with fMRI using an inhibitory task[J]. J Neurosci, 2014, 34(43):14260-14271. DOI: 10.1523/jneurosci.1111-14.2014.
|
[20] |
AGOSTA F, CANU E, INUGGI A,et al. Resting state functional connectivity alterations in primary lateral sclerosis[J]. Neurobiol Aging, 2014, 35(4):916-925. DOI: 10.1016/j.neurobiolaging.2013.09.041.
|
[21] |
SMALLWOOD SHOUKRY R F, CLARK M G, FLOETER M K. Resting state functional connectivity is decreased globally across the C9orf72 mutation spectrum[J]. Front Neurol, 2020, 11:598474. DOI: 10.3389/fneur.2020.598474.
|
[22] |
|
[23] |
LULÉ D, BÖHM S, MÜLLER H P,et al. Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis[J]. Cortex, 2018, 101:163-171. DOI: 10.1016/j.cortex.2018.01.004.
|
[24] |
MARJANOVIC I V, SELAK-DJOKIY B, PERIY S,et al. Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia[J]. J Neurol, 2017, 264(6):1091-1098. DOI: 10.1007/s00415-017-8495-y.
|
[25] |
PATEL A N, SAMPSON J B. Cognitive profile of C9orf72 in frontotemporal dementia and amyotrophic lateral sclerosis[J]. Curr Neurol Neurosci Rep, 2015, 15(9):59. DOI: 10.1007/s11910-015-0582-9.
|
[26] |
BERTRAND A, WEN J H, RINALDI D,et al. Early cognitive,structural,and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years[J]. JAMA Neurol, 2018, 75(2):236-245. DOI: 10.1001/jamaneurol.2017.4266.
|
[27] |
ANDERSEN P M, AL-CHALABI A. Clinical genetics of amyotrophic lateral sclerosis:what do we really know?[J]. Nat Rev Neurol, 2011, 7(11):603-615. DOI: 10.1038/nrneurol.2011.150.
|
[28] |
LING S C. Synaptic paths to neurodegeneration:the emerging role of TDP-43 and FUS in synaptic functions[J]. Neural Plast, 2018, 2018:8413496. DOI: 10.1155/2018/8413496.
|
[29] |
WEI Q Q, CHEN X P, CHEN Y P,et al. Unique characteristics of the genetics epidemiology of amyotrophic lateral sclerosis in China[J]. Sci China Life Sci, 2019, 62(4):517-525. DOI: 10.1007/s11427-018-9453-x.
|
[30] |
ANDERSEN P M, AL-CHALABI A. Clinical genetics of amyotrophic lateral sclerosis:what do we really know?[J]. Nat Rev Neurol, 2011, 7(11):603-615. DOI: 10.1038/nrneurol.2011.150.
|
[31] |
CANNAS A, BORGHERO G, FLORIS G L,et al. The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms[J]. Neurogenetics, 2013, 14(2):161-166. DOI: 10.1007/s10048-013-0360-2.
|
[32] |
MILANOWSKI L, SITEK E J, DULSKI J,et al. Cognitive and behavioral profile of Perry syndrome in two families[J]. Parkinsonism Relat Disord, 2020, 77:114-120. DOI: 10.1016/j.parkreldis.2020.05.019.
|
[33] |
KONNO T, ROSS O A, TEIVE H A G,et al. DCTN1-related neurodegeneration:Perry syndrome and beyond[J]. Parkinsonism Relat Disord, 2017, 41:14-24. DOI: 10.1016/j.parkreldis.2017.06.004.
|
[34] |
CHO H, SHUKLA S. Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis[J]. Pharmaceuticals (Basel), 2020, 14(1):29. DOI: 10.3390/ph14010029.
|
[35] |
JIANG J, ZHU Q, GENDRON T F,et al. Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs[J]. Neuron, 2016, 90(3):535-550. DOI: 10.1016/j.neuron.2016.04.006.
|
[36] |
POZZI S, THAMMISETTY S S, CODRON P,et al. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology[J]. J Clin Invest, 2019, 129(4):1581-1595. DOI: 10.1172/JCI123931.
|
[37] |
KNIPPENBERG S, RATH K J, BÖSELT S,et al. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression,prolongs survival and increases expression of endogenous neurotrophic factors[J]. J Tissue Eng Regen Med, 2017, 11(3):751-764. DOI: 10.1002/term.1972.
|
[38] |
BERRY J D, CUDKOWICZ M E, WINDEBANK A J,et al. NurOwn,phase 2,randomized,clinical trial in patients with ALS:safety,clinical,and biomarker results[J]. Neurology, 2019, 93(24):e2294-2305. DOI: 10.1212/WNL.0000000000008620.
|
[39] |
CANOSA A, PALUMBO F, IAZZOLINO B,et al. The interplay among education,brain metabolism,and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis[J]. Neurobiol Aging, 2021, 98:205-213. DOI: 10.1016/j.neurobiolaging.2020.11.010.
|
[40] |
BETTCHER B M, GROSS A L, GAVETT B E,et al. Dynamic change of cognitive reserve:associations with changes in brain,cognition,and diagnosis[J]. Neurobiol Aging, 2019, 83:95-104. DOI: 10.1016/j.neurobiolaging.2019.08.016.
|
[41] |
MAJMUDAR S, WU J, PAGANONI S. Rehabilitation in amyotrophic lateral sclerosis:why it matters[J]. Muscle Nerve, 2014, 50(1):4-13. DOI: 10.1002/mus.24202.
|
[42] |
KIOUSI V, ARNAOUTOGLOU M, PRINTZA A. Speech and language intervention for language impairment in patients in the FTD-ALS spectrum[J]. Hell J Nucl Med,2019,22(Suppl):133-146.
|
[43] |
ELAMIN M, BEDE P, BYRNE S,et al. Cognitive changes predict functional decline in ALS:a population-based longitudinal study[J]. Neurology, 2013, 80(17):1590-1597. DOI: 10.1212/WNL.0b013e31828f18ac.
|